s is
ong. In medicine generally, the figure is 90 something percent.
This is the guy who told us that anthropogenic global warming stopped in 19
NT's published claims suggest to me that he is decidedly gullible, and inca pable of admitting that he has been mislead. His opinions should be treated with particular scepticism, not least because he is remarkably unwilling t o specify the precise area where he thinks he has in-depth knowledge.
some issues with it in practice:
ably pay researchers that give them the best results. It takes no genius to work out how that goes.
Industrial research is routinely done for profit (or as precaution against future loss). Academic research is largely motivated by a desire to get pub lications in high prestige journals, and citations for the stuff that gets published.
Pharmacy companies don't normally publish negative results, but that's the only obvious distortion in the process. Academics also find it hard to publ ish negative results.
most cases they aren't. When they are paid to they're under the profit moti ve, which encourages an awful lot of overlooking & more.
Only some of them are influenced by the profit motive. A large chunk of the motivation for publication is to get noticed - even in profit-driven indus try.
Lying to get noticed does happen
but getting found out has catastrophic consequences.
criticism. This occurs for a few reasons, including
True.
False. An irritated author may react with a counter-blast, but that's anoth er citation. "There is no such thing as bad publicity".P.T. Barnum.
Sloman A. W. ?Comment on ?A versatile thermoelectric temper ature controller with 10 mK reproducibility and 100 mK absolute accuracy? ?? [Rev. Sci. Instrum. 80, 126107 (2009)] ?, Review of Scientif ic Instruments 82, 27101 - 027101-2 (2011).
think their voice won't be heard.
A Ph.D. is a remarkably narrow qualification. Mine is in Physical Chemistry , but my publications are entirely within the instrumentation literature. Editors couldn't care less whether you have a Ph.D. and everybody (you exce pted) seems to know that.
If better than any other idea that anybody has come up with.
where the author has no connection with their treatment and is not sponsore d by interested parties. You've got much higher sample numbers, much longer study lengths & as much as practical of the money motive is removed. Imho such data gathering should be automatic across the board for any developed nation's health service. It doesn't solve all the problems but it's a lot b etter.
Cochrane collaboration.
It dates back to 1993, and a lot of what it does are meta-analyses of lots of data collected by people with an economic interest in knowing what happe ns to patients.
NT is absolutely right - for once - in saying that such data-gathering shou ld be built into any developed nation's health service, but it has only rec ently become a practical option, and privacy issues do complicate the proce ss.
rently shall we say messy field, and believing what one is told is generall y naive.
NT is choosy about what he is told, and what he chooses to believe. My impr ession is that he has made quite a few bad choices, and the even worst choi ce of sticking to them.